These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22284418)

  • 1. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis.
    Murthy A; Shao YW; Narala SR; Molyneux SD; Zúñiga-Pflücker JC; Khokha R
    Immunity; 2012 Jan; 36(1):105-19. PubMed ID: 22284418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of impaired Notch signalling in atopic dermatitis.
    Melnik BC
    Acta Derm Venereol; 2015 Jan; 95(1):5-11. PubMed ID: 24853951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling.
    Weber S; Niessen MT; Prox J; Lüllmann-Rauch R; Schmitz A; Schwanbeck R; Blobel CP; Jorissen E; de Strooper B; Niessen CM; Saftig P
    Development; 2011 Feb; 138(3):495-505. PubMed ID: 21205794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.
    Caolo V; Swennen G; Chalaris A; Wagenaar A; Verbruggen S; Rose-John S; Molin DG; Vooijs M; Post MJ
    Angiogenesis; 2015 Jan; 18(1):13-22. PubMed ID: 25218057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.
    Franzke CW; Cobzaru C; Triantafyllopoulou A; Löffek S; Horiuchi K; Threadgill DW; Kurz T; van Rooijen N; Bruckner-Tuderman L; Blobel CP
    J Exp Med; 2012 Jun; 209(6):1105-19. PubMed ID: 22565824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth muscle cells relay acute pulmonary inflammation via distinct ADAM17/ErbB axes.
    Dreymueller D; Martin C; Schumacher J; Groth E; Boehm JK; Reiss LK; Uhlig S; Ludwig A
    J Immunol; 2014 Jan; 192(2):722-31. PubMed ID: 24342803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17/EGFR axis promotes transglutaminase-dependent skin barrier formation through phospholipase C γ1 and protein kinase C pathways.
    Wolf C; Qian Y; Brooke MA; Kelsell DP; Franzke CW
    Sci Rep; 2016 Dec; 6():39780. PubMed ID: 28004780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin.
    Dumortier A; Durham AD; Di Piazza M; Vauclair S; Koch U; Ferrand G; Ferrero I; Demehri S; Song LL; Farr AG; Leonard WJ; Kopan R; Miele L; Hohl D; Finke D; Radtke F
    PLoS One; 2010 Feb; 5(2):e9258. PubMed ID: 20174635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.
    Scholz F; Schulte A; Adamski F; Hundhausen C; Mittag J; Schwarz A; Kruse ML; Proksch E; Ludwig A
    J Invest Dermatol; 2007 Jun; 127(6):1444-55. PubMed ID: 17363916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ADAM family: Insights into Notch proteolysis.
    Christian LM
    Fly (Austin); 2012; 6(1):30-4. PubMed ID: 22513479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of metalloproteinase ADAM17 in regulating ICOS ligand-mediated humoral immune responses.
    Marczynska J; Ozga A; Wlodarczyk A; Majchrzak-Gorecka M; Kulig P; Banas M; Michalczyk-Wetula D; Majewski P; Hutloff A; Schwarz J; Chalaris A; Scheller J; Rose-John S; Cichy J
    J Immunol; 2014 Sep; 193(6):2753-63. PubMed ID: 25108021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Barrier Defects Caused by Keratinocyte-Specific Deletion of ADAM17 or EGFR Are Based on Highly Similar Proteome and Degradome Alterations.
    Tholen S; Wolf C; Mayer B; Knopf JD; Löffek S; Qian Y; Kizhakkedathu JN; Biniossek ML; Franzke CW; Schilling O
    J Proteome Res; 2016 May; 15(5):1402-17. PubMed ID: 27089454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?
    Melnik BC
    Exp Dermatol; 2014 Oct; 23(10):696-700. PubMed ID: 24889007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal ADAM17 is dispensable for notch activation.
    Groot AJ; Cobzaru C; Weber S; Saftig P; Blobel CP; Kopan R; Vooijs M; Franzke CW
    J Invest Dermatol; 2013 Sep; 133(9):2286-8. PubMed ID: 23657465
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.
    Kavian N; Servettaz A; Mongaret C; Wang A; Nicco C; Chéreau C; Grange P; Vuiblet V; Birembaut P; Diebold MD; Weill B; Dupin N; Batteux F
    Arthritis Rheum; 2010 Nov; 62(11):3477-87. PubMed ID: 20583103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity.
    Demehri S; Liu Z; Lee J; Lin MH; Crosby SD; Roberts CJ; Grigsby PW; Miner JH; Farr AG; Kopan R
    PLoS Biol; 2008 May; 6(5):e123. PubMed ID: 18507503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells.
    Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X
    Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM17 at the interface between inflammation and autoimmunity.
    Lisi S; D'Amore M; Sisto M
    Immunol Lett; 2014 Nov; 162(1 Pt A):159-69. PubMed ID: 25171914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectodomain shedding of the Notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event.
    Parr-Sturgess CA; Rushton DJ; Parkin ET
    Biochem J; 2010 Dec; 432(2):283-94. PubMed ID: 20819075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
    Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
    Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.